These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 18202490)

  • 1. Beneficial effects of maintenance intravenous iron saccharate in hemodialysis patients.
    Al-Mueilo SH
    Saudi J Kidney Dis Transpl; 2005; 16(2):146-53. PubMed ID: 18202490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intravenous iron saccharate on the requirements of erythropoietin in hemodialysis patients.
    Shaheen FA; Souqiyyeh MZ; Akeel N
    Saudi J Kidney Dis Transpl; 2002; 13(2):131-40. PubMed ID: 17660651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H; Wang SX
    Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of iron supply for erythropoietin therapy.
    Sunder-Plassmann G; Hörl WH
    Nephrol Dial Transplant; 1995 Nov; 10(11):2070-6. PubMed ID: 8643170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N; Osman-Malik Y; Frinak S; Besarab A
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
    Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B
    Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
    Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of iron loading on peripheral blood lymphocyte subsets and on circulating cytokine levels in iron-depleted hemodialysis patients receiving erythropoietin.
    Tsouchnikas I; Tsilipakou M; Daniilidis M; Kyriazis G; Pasadakis P; Parapanissiou E; Vargemezis V; Tsakiris D
    Nephron Clin Pract; 2007; 107(3):c97-102. PubMed ID: 17890877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance intravenous iron therapy in hepmodialysis patients receiving recombinant human erythropoientin.
    Romeh SA; Huraib S; Murray N; Tanimu D; Flaiw A; Iqbal A; Al Ghamdi G; Quadri K
    Saudi J Kidney Dis Transpl; 1999; 10(1):21-5. PubMed ID: 18212409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis.
    Coronel F; Herrero JA; Montenegro J; Fernandez C; Gandara A; Conesa J; Rivera MT; Torrente J; Portolés J; Gomez-Martino JR
    J Nephrol; 2003; 16(5):697-702. PubMed ID: 14733416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous Iron Saccharate in Hemodialysis Patients Receiving r-HuEPO.
    Al-Momen AK; Huraib SO; Mitwalli AH; Al-Wakeel J; Al-Yamani MJ; Abu-Aisha H; Said R
    Saudi J Kidney Dis Transpl; 1994; 5(2):168-72. PubMed ID: 18583828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble transferrin receptor is correlated with erythropoietin sensitivity in dialysis patients.
    Daschner M; Mehls O; Schaefer F
    Clin Nephrol; 1999 Oct; 52(4):246-52. PubMed ID: 10543327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative response to single or divided doses of parenteral iron for functional iron deficiency in hemodialysis patients receiving erythropoietin (EPO).
    Saltissi D; Sauvage D; Westhuyzen J
    Clin Nephrol; 1998 Jan; 49(1):45-8. PubMed ID: 9491286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hematological and iron parameters to predict mortality in ESRD].
    Cantaro S; Piva E
    G Ital Nefrol; 2005; 22 Suppl 31():S135-9. PubMed ID: 15786388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of intravenous injection of iron saccharate in haemodialysis patients.
    Sunder-Plassmann G; Hörl WH
    Nephrol Dial Transplant; 1996 Sep; 11(9):1797-802. PubMed ID: 8918625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous ascorbic acid in hemodialysis patients with functional iron deficiency: a clinical trial.
    Giancaspro V; Nuzziello M; Pallotta G; Sacchetti A; Petrarulo F
    J Nephrol; 2000; 13(6):444-9. PubMed ID: 11132761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with a large dose (500 mg) of intravenous iron dextran and iron saccharate in peritoneal dialysis patients.
    Prakash S; Walele A; Dimkovic N; Bargman J; Vas S; Oreopoulos D
    Perit Dial Int; 2001; 21(3):290-5. PubMed ID: 11475345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels.
    Maruyama Y; Nakayama M; Yoshimura K; Nakano H; Yamamoto H; Yokoyama K; Lindholm B
    Nephrol Dial Transplant; 2007 May; 22(5):1407-12. PubMed ID: 17264097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in intravenous iron use internationally and over time: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Bailie GR; Larkina M; Goodkin DA; Li Y; Pisoni RL; Bieber B; Mason N; Tong L; Locatelli F; Marshall MR; Inaba M; Robinson BM
    Nephrol Dial Transplant; 2013 Oct; 28(10):2570-9. PubMed ID: 24078642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.